U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H19FN6
Molecular Weight 338.3821
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SB-220025

SMILES

NC1=NC(=CC=N1)C2=C(N=CN2C3CCNCC3)C4=CC=C(F)C=C4

InChI

InChIKey=VSPFURGQAYMVAN-UHFFFAOYSA-N
InChI=1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24)

HIDE SMILES / InChI

Molecular Formula C18H19FN6
Molecular Weight 338.3821
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
60.0 nM [IC50]
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:01:32 GMT 2023
Edited
by admin
on Sat Dec 16 10:01:32 GMT 2023
Record UNII
MX95H97VRG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SB-220025
Code English
SB 220025
Code English
2-PYRIMIDINAMINE, 4-(4-(4-FLUOROPHENYL)-1-(4-PIPERIDINYL)-1H-IMIDAZOL-5-YL)-
Systematic Name English
3ERK
Common Name English
4-(4-(4-FLUOROPHENYL)-1-(4-PIPERIDINYL)-1H-IMIDAZOL-5-YL)-2-PYRIMIDINAMINE
Systematic Name English
SB220025
Code English
Code System Code Type Description
CHEBI
82713
Created by admin on Sat Dec 16 10:01:32 GMT 2023 , Edited by admin on Sat Dec 16 10:01:32 GMT 2023
PRIMARY
FDA UNII
MX95H97VRG
Created by admin on Sat Dec 16 10:01:32 GMT 2023 , Edited by admin on Sat Dec 16 10:01:32 GMT 2023
PRIMARY
PUBCHEM
5164
Created by admin on Sat Dec 16 10:01:32 GMT 2023 , Edited by admin on Sat Dec 16 10:01:32 GMT 2023
PRIMARY
DRUG BANK
DB04338
Created by admin on Sat Dec 16 10:01:32 GMT 2023 , Edited by admin on Sat Dec 16 10:01:32 GMT 2023
PRIMARY
CAS
165806-53-1
Created by admin on Sat Dec 16 10:01:32 GMT 2023 , Edited by admin on Sat Dec 16 10:01:32 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR